NCT00687063View on ClinicalTrials.gov

Observational Study of Safety and Efficacy of Levemir® in Type 2 Diabetes

CompletedOBSERVATIONAL

Enrollment

10,008

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin detemir

Start dose and frequency of insulin detemir is to be decided by physician. The choice of patient is also at the discretion of Physician

Trial Locations (1)

560001

Bangalore

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY